Handelsinvest Investeringsforvaltning’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $309K | Sell |
2,241
-1,164
| -34% | -$160K | 0.15% | 161 |
|
|
2023
Q4 | $449K | Buy |
+3,405
| New | +$449K | 0.18% | 152 |
|
|
2020
Q4 | – | Sell |
-45,000
| Closed | -$4.33M | – | 125 |
|
|
2020
Q3 | $4.33M | Buy |
45,000
+10,000
| +29% | +$962K | 0.82% | 46 |
|
|
2020
Q2 | $4.27M | Sell |
35,000
-5,000
| -13% | -$610K | 0.89% | 41 |
|
|
2020
Q1 | $3.46M | Hold |
40,000
| – | – | 0.92% | 44 |
|
|
2019
Q4 | $4.3M | Sell |
40,000
-10,000
| -20% | -$1.08M | 0.86% | 40 |
|
|
2019
Q3 | $4.51M | Buy |
50,000
+5,600
| +13% | +$505K | 0.99% | 36 |
|
|
2019
Q2 | $3.75M | Hold |
44,400
| – | – | 0.79% | 39 |
|
|
2019
Q1 | $3.91M | Hold |
44,400
| – | – | 0.87% | 38 |
|
|
2018
Q4 | $3.17M | Hold |
44,400
| – | – | 0.79% | 44 |
|
|
2018
Q3 | $5.46M | Hold |
44,400
| – | – | 1.12% | 34 |
|
|
2018
Q2 | $4.36M | Hold |
44,400
| – | – | 0.96% | 40 |
|
|
2018
Q1 | $3.68M | Hold |
44,400
| – | – | 0.82% | 42 |
|
|
2017
Q4 | $3.45M | Hold |
44,400
| – | – | 0.76% | 40 |
|
|
2017
Q3 | $2.72M | Hold |
44,400
| – | – | 0.64% | 40 |
|
|
2017
Q2 | $2.04M | Buy |
44,400
+24,700
| +125% | +$1.14M | 0.51% | 46 |
|
|
2017
Q1 | $853K | Buy |
19,700
+5,000
| +34% | +$216K | 0.24% | 82 |
|
|
2016
Q4 | $569K | Hold |
14,700
| – | – | 0.2% | 81 |
|
|
2016
Q3 | $744K | Buy |
+14,700
| New | +$744K | 0.27% | 81 |
|